LiveWire Ergogenics, Inc.
LVVV · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | – | $0 | $0 | $0 |
| % Growth | – | 15.2% | -30.5% | – |
| Cost of Goods Sold | – | $0 | $0 | $0 |
| Gross Profit | – | $0 | $0 | $0 |
| % Margin | – | 93.5% | 92.5% | 94.8% |
| R&D Expenses | – | $0 | $0 | $0 |
| G&A Expenses | – | $0 | $0 | $0 |
| SG&A Expenses | – | $0 | $0 | $0 |
| Sales & Mktg Exp. | – | $0 | $0 | $0 |
| Other Operating Expenses | – | $0 | $0 | $0 |
| Operating Expenses | – | $0 | $0 | $0 |
| Operating Income | – | $0 | -$0 | $0 |
| % Margin | – | 86.9% | -6.6% | 33% |
| Other Income/Exp. Net | – | -$0 | $0 | $0 |
| Pre-Tax Income | – | -$0 | $0 | $0 |
| Tax Expense | – | $0 | $0 | $0 |
| Net Income | – | -$0 | $0 | $0 |
| % Margin | – | -20.7% | 48.7% | 47.4% |
| EPS | – | 0 | 0 | 0 |
| % Growth | – | – | – | – |
| EPS Diluted | – | 0 | 0 | 0 |
| Weighted Avg Shares Out | – | 2 | 2 | 2 |
| Weighted Avg Shares Out Dil | – | 2 | 2 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | – | $0 | $0 | $0 |
| Interest Expense | – | $0 | $0 | $0 |
| Depreciation & Amortization | – | $0 | $0 | $0 |
| EBITDA | – | $0 | $0 | $0 |
| % Margin | – | 93.3% | 111.7% | 112% |